Scientists have found a new way to coax stem cells into the desired cell type by mimicking the body’s natural approach to programming these cells.
For the first time in the US, a 28-year old patient with Duchenne’s muscular dystrophy, Ryan Benton, received mesenchymal stem cell treatment based on umbilical cord tissue.
The scientists have proved once more the positive impact of exercises on the body. In addition to its effects on heart, weight, and overall health, moderate exercising helps to restore muscle mass which usually diminishes as we age.
This study demonstrates the impact of fetal stem cells (FSCs) on functional capacity and life quality of DMD patients and the ability of FSCs to prevent DMD-related complicationsAll news
Cell Therapy Center EmCell offers stem cell therapy for different types of muscular dystrophy. Fetal stem cells (FCSs) have proved to be one of the options leading not only to reduced muscle wasting but even to some regression in the main symptoms of this disease.
In the course of MD treatment with stem cells, pools of genetically healthy cells are created in the patient’s body. These cell pools are capable of producing dystrophin, which can then penetrate affected cells. Moreover, during the course of determination, differentiation, and morphogenesis, transplanted stem cells produce pools of specialized cells that the patient’s body needs, such as muscular, nervous, endothelial, and so on. Stem cell treatment offers two main kinds of result:
MD treatment takes place at different stages of the disease, at different ages, at different levels of muscle atrophy, and at different levels of patient capacity for independent motion—bedridden, in a wheelchair, or able to walk independently.
Fetal stem cells facilitate the synthesis of dystrophin, the deficiency of which causes the disease. Our treatment helps lead to:
Typically, MD treatment at Cell Therapy Center EmCell lasts 2 days.